Clinical Trial Update: The Combination of High-dose Dexamethasone and Acetylcysteine as the Treatment of Newly-diagnosed ITP [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating high-dose dexamethasone plus acetylcysteine for newly diagnosed immune thrombocytopenia is in early stages with status not reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• Acetylcysteine (Acetylcysteine)
• high-dose dexamethasone

Snippet

Sponsor: Peking University People's Hospital | Conditions: Immune Thrombocytopenia | Phase 2 | Status: UNKNOWN